Abbott and Surmodics announced that the companies have entered into an agreement whereby Abbott will have exclusive worldwide commercialization rights for Surmodics’ SurVeil® drug-coated balloon to treat the superficial femoral artery, which is currently being evaluated in a U.S. pivotal clinical trial. Separately, Abbott also received options to negotiate agreements for Surmodics’ below-the-knee and arteriovenous (AV) fistula drug-coated balloon products, …

VitalConnect®, Inc. announced the launch of the Vista Solution™ platform. The Vista Solution platform enables wireless, real-time, continuous patient monitoring, and delivers a seamless feed of patient data that supports timely caregiver analysis in the hospital or at home. The new platform integrates the company’s existing VitalPatch® wearable biosensor, which is the only FDA cleared Class II device that continuously …

Clarify Medical announced that the United States Patent and Trademark Office has issued US patent 9,901,747, entitled “Phototherapy Light Engine.” The patent covers a precision, targeted phototherapy device using UVB LEDs, reflectors, window filter and thermal management system to optimize therapeutic power and uniformity of narrowband UVB light treatment. The Clarify System’s patented light engine has significant advantages compared to …